Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells

Molecular Cancer Therapeutics

Volumn 5, Issue 5, 2006, Pages 1227-1238

  Zhang, Qunzhou ^a   Tang, Xudong ^a   Lu, QingYi ^b   Zhang, ZuoFeng ^c   Rao, Jianyu ^d   Le, Anh D ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; PROTEIN KINASE B; VASCULOTROPIN;

ARTICLE; CANCER PREVENTION; CARCINOMA CELL; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; ENZYME INHIBITION; FEMALE; GENE TARGETING; HEPATOMA CELL; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UTERINE CERVIX CARCINOMA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOGENESIS INHIBITORS; ANTICARCINOGENIC AGENTS; CARCINOMA; CARCINOMA, HEPATOCELLULAR; CATECHIN; CELL HYPOXIA; CULTURE MEDIA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; LIVER NEOPLASMS; PLANT EXTRACTS; RNA, MESSENGER; SIROLIMUS; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33745058978     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-05-0490     Document Type: Article

References (70)

1. Horie N, Hirabayashi N, Takahashi Y, et al. Synergistic effect of green tea catechins on cell growth and apoptosis induction in gastric carcinoma cells. Biol Pharm Bull 2005;28:574-9.
2. Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J Nutr 2003;133:3262-7S.
3. Nihal M, Ahmad N, Mukhtar H, et al. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gaIlate on human melanoma: possible implications for the chemoprevention of melanoma. Int J Cancer 2005; 114:513-21.
4. Baliga MS, Meleth S, Katiyar SK. Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clin Cancer Res 2005;11: 1918-27.
5. Kondo T, Ohta T, Igura K, et al. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Lett 2002; 180:139-44.
6. Tang FY, Nguyen N, Meydani M. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J Cancer 2003; 106:871-8.
7. Kojima-Yuasa A, Hue JJ, Knnedy DO, et al. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors. Life Sci 2003;73:1299-313
8. Fassina G, Vene R, Morini M, et al. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin Cancer Res 2004;10:4865-73.
9. Liao J, Yang GY, Park ES, et al. Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr Cancer 2004;48:44-53.
10. Adhami VM, Siddiqui IA, Ahmad N, et al. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res 2004;64: 8715-22.
11. Yamakawa S, Asai T, Uchida T, et al. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1 -MMP, and tumor angiogenesis. Cancer Lett 2004;210:47-55.
12. Jung YD, Ellis LM. Inhibition of tumor invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Int J Exp Pathol 2001;82:309-16.
13. Yang J, Wei D, Liu J. Repressions of MMP-9 expression and NF-κB localization are involved in inhibition of lung carcinoma 95-D cell invasion by (-)-epigallocatechin-3-gallate. Biomed Pharmacother 2005; 59:98-103.
14. Slivova V, Zaloga G, Dernichele SJ, et al. Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells. Nutr Cancer 2005;52:66-73.
15. Lu QY, Jin YS, Pantuck A, et al. Green tea extract modulates actin remodeling via Rho activity in an in vitro multistep carcinogenic model. Clin Cancer Res 2005;11:1675-83.
16. Qanungo S, Des M, Haldar S, et al. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 2005;26:958-67.
17. Roy AM, Baliga MS, Katiyar SK. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Mol Cancer Ther 2005;4:81-90.
18. Liang YC, Lin-Shiau SH, Chen CF, et al. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. J Cell Biochem 1999;75:1-12.
19. Ahmad N, Cheng P, Mukhtar H. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun 2000;275:328-34.
20. Yang CS. Inhibition of carcinogenesis by tea. Nature 1997;389: 134-5.
21. Sato D. Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea. Int J Urol 1999;6: 93-9.
22. Shimizu M, Weinstein IB. Modulation of signal transduction by tea catechins and related phytochemicals. Mutat Res. In press 2005.
23. Sah JF, Balasubramanian S, Eckert RL, et al. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 2004;279:12755-62.
24. Shimizu M, Deguchi A, Lim JT, et al. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 2005;11: 2735-46.
25. Shimizu M, Deguchi A, Joe A, et al. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J Exp Ther Oncol 2005;5:69-78.
26. Masuda M, Suzui M, Weinstein IB, Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 2001;7:4220-9.
27. Masuda M, Suzui M, Lim JT, et al. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res 2003;9: 3486-91.
28. Pianetti S, Guo SQ, Kavanagh KT, et al. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/Neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res 2002;62: 652-5.
29. Liang YC, Lin-shiau SY, Chen CF, et al. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem 1997;67:55-65.
30. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002;42:25-54.
31. Shimizu M, Deguchi A, Hara Y, et al. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochem Biophys Res Commun 2005;334:947-53.
32. Folkman J. Fighting cancer by attacking its blood supply. Sci Am 1996;275:150-4.
33. Jung YD, Kim MS, Shin BA, et al. EGCG, a major component of green tea, inhibits tumor growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer 2001;84:844-50.
34. Masuda M, Suzui M, Lim JT, et al. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol 2002;2:350-9.
35. Sartippour MR, Shao ZM, Heber D, et al. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr 2002;132:2307-11.
36. Basini G, Bianco F, Grasselli F. EGCG, a major component of green tea, inhibits VEGF production by swine granulosa cells. Biofactors 2005;23:25-33.
37. Lamy S, Gingras D, Beliveau R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res 2002;62: 381-5.
38. 2 tension. Proc Natl Acad Sci U S A 1995;92:5510-4.
39. Masson N, Willam C, Maxwell PH, et al. Independent function of two destruction domain in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J 2001;20:5197-206.
40. 2 sensing. Science 2001;292:464-8.
41. 2-regulated prolyl hydroxylation. Science 2001;292:468-72.
42. Epstein AC, Gleadle JM, McNeill LA, at al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulates HIF by prolyl hydroxylation. Cell 2001;107:43-54.
43. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U SA 1998;95:7987-92.
44. Kamura T, Sato S, Iwai K, et al. Activation of HIF-1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci U S A 2000;97:10430-5.
45. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor-1. Mol Cell Biol 1996;16:4604-13.
46. Zundel W, Schindler C, Haas-Kogan D, et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 2000;14:391-6.
47. c-Src leads to elevated hypoxia-inducible factor (HIF)-1α expression under normoxia. J Biol Chem 2002;277:42919-25.
48. Stiehl DP, Jelkmann W, Wenger RH, et al. Normoxia induction of the hypoxia-inducible factor 1α by insulin and interleukin-1β involves the phosphatidylinositol 3-kinase pathway. FEBS Lett 2002; 512:157-62.
49. Sandau KB, Zhou J, Kietzmann T, et al. Regulation of the hypoxia-inducible factor 1α by the inflammatory mediators nitric oxide and tumor necrosis factor-α in contrast to desferroxamine and phenylarsine oxide. J Biol Chem 2001;276:39805-11.
50. Hellwig-Burgel T, Rutkowski K, Metzen E, at al. Interleukin-1β and tumor necrosis factor-α-stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999;94:1561-7.
51. Xu Q, Briggs J, Park S, et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 2005;24:5552-60.
52. Fukuda R, Hirota K, Fan F, et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002; 277:38205-11.
53. Treins C, Giorgetti-Peraldi S, Murdaca J, et al. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/ target of rapamycin-dependent signaling pathway. J Biol Chem 2002;277:27975-81.
54. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 1998;394:485-90.
55. Krishnamachary B, Berg-Dixon S, Kelly B, et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003; 63:1138-43.
56. Piret J, Lecocq C, Toffoli S, et al. Hypoxia and CoCl2 protect HepG2 cells against serum starvation- and t-BHP-induced apoptosis: a possible anti-apoptotic role for HIF-1. Exp Cell Res 2004;295:340-9.
57. Zhang QZ, Zhang ZF, Rao JY, et al. Treatment with siRNA and antisense oligonucleotides targeted to HIF-1 α induced apoptosis in human tongue squamous cell carcinomas. Int J Cancer 2004;111:849-57.
58. Bimer P, Schindi M, Obermair A, et al. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000; 60:4693-6.
59. Zagzag D, Zhong H, Scaizitti JM, et al. Expression of hypoxia-inducible factor 1α in brain tumors: association with angiogenesis, invasion, and progression. Cancer 2000;88:2606-18.
60. Jiang BH, Agani F, Passaniti A, et al. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 1997;57:5328-35.
61. Powis G, Kirkpatrick L. Hypoxia inducible factor-1α as a cancer drug target. Mol Cancer Ther 2004;3:647-54.
62. Zhou YD, Kim YP, Li XC, et al. Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts. J Nat Prod 2004;67:2063-9.
63. Thomas R, Kim MH. Epigallocatechin gallate inhibits HIF-1α degradation in prostate cancer cells. Biochem Biophys Res Commun 2005; 334: 543-8.
64. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005;23: 1011-27.
65. Haddad JJ, Harb HL. Cytokines and the regulation of hypoxia-inducible factor (HIF)-1α. Int Immunopharmacol 2005;5:461-83.
66. Semenza GL. Signal transduction to hypoxia-inducible factor 1α. Biochem Pharmacol 2002;64:993-8.
67. Cao Z, Fang J, Xia C, at al. trans-3,4, 5′-Tri hydroxystibene inhibits hypoxia-inducible factor 1α and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res 2004;10: 5253-63.
68. Gingras A, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev 2001;15:807-26.
69. Berven LA, Crouch MF. Cellular function of p70S6K: a role in regulating cell motility. Immunol Cell Biol 2000;78:447-51.
70. Zhang QZ, Tang XD, Lu OY, et al. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1α and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther 2005;4:1465-74.